表 3.
CD4+T淋巴细胞与临床实验室指标之间的关系
Relationship between CD4+T lymphocyte cells reduction and clinical laboratory index
| Items | Reduction group (n=14) | Normal group (n=18) | P |
| ANA, antinuclear antibody; Scl-70, anti-Scl-70; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; IgG, immunoglobulin G; IgM, immunoglobulin M; IgA, immunoglobulin A; C3, complement 3; C4, complement 4. | |||
| Age/years，x±s | 51.64±14.56 | 49.72±13.17 | 0.699 |
| Women，n(%) | 13 (92.86) | 18 (100) | 1.000 |
| Disease duration/years，M(P25, P75) | 8.50 (1，28) | 3.75 (0.5，20) | 0.085 |
| Raynaud‘s phenomenon，n(%) | 14 (100) | 12 (66.67) | 0.024 |
| Diffuse cutaneous changes，n(%) | 13 (92.86) | 12 (66.67) | 0.104 |
| Fingertip ulcer，n(%) | 3 (21.43) | 4 (22.22) | 1.000 |
| Pulmonary interstitial fibrosis，n(%) | 12 (83.71) | 11 (61.11) | 0.235 |
| ANA，n(%) | 13 (92.86) | 16 (88.89) | 1.000 |
| Scl-70, n(%) | 5 (35.71) | 6 (33.33) | 1.000 |
| ESR/(mm/h), M(P25, P75) | 25 (18.00，41.50) | 9.00 (7.50，14.50) | ＜0.001 |
| CRP/(mg/L), M(P25, P75) | 7.93 (1.76，14.72) | 2.21 (0.47，3.14) | 0.018 |
| IgG/(g/L), M(P25, P75) | 14.25 (10.20，19.70) | 11.05 (9.65，15.40) | 0.180 |
| IgM/(g/L), M(P25, P75) | 0.81 (0.64，1.05) | 0.85 (0.66，1.04) | 0.955 |
| IgA/(g/L), x±s | 2.11±1.28 | 2.24±1.49 | 0.798 |
| C3/(g/L), x±s | 0.85±0.24 | 0.89±0.17 | 0.583 |
| C4/(g/L), x±s | 0.19±0.08 | 0.19±0.07 | 0.979 |